Yan Kong

Peking University - Key Laboratory of Carcinogenesis and Translational Research

No. 38 Xueyuan Road

Haidian District

Beijing, Beijing 100871

China

SCHOLARLY PAPERS

2

DOWNLOADS

50

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Axitinib in Combination with Toripalimab, a Humanized IgG4 mAb Against Programmed Death-1 (PD-1) in Patients with Metastatic Mucosal Melanoma: A Non-Randomized, Open-Label, Dose-Finding, and Cohort-Expansion Phase 1b Trial

Number of pages: 148 Posted: 24 Jan 2019
Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, Peking University - Key Laboratory of Carcinogenesis and Translational Research, OrigiMed, Inc., Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Shanghai Junshi Biosciences Co., LTD, Harvard University - Medical School and Peking University - Key Laboratory of Carcinogenesis and Translational Research
Downloads 34 (466,222)

Abstract:

Loading...

Mucosal, Melanoma, anti-PD-1 antibody, Axitinib

2.

Kinetic Inference Resolves Epigenetic Mechanism of Drug Resistance in Melanoma

CANCER-CELL-D-19-00753
Number of pages: 75 Posted: 21 Aug 2019
California Institute of Technology - Division of Chemistry and Chemical Engineering, University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), California Institute of Technology - Division of Biology and Biological Engineering, Institute for Systems Biology, Peking University - Key Laboratory of Carcinogenesis and Translational Research, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Biology and Biological Engineering, University of California, Los Angeles (UCLA) - Department of Medicine, City of Hope - Department of Molecular and Cellular Biology, California Institute of Technology - Division of Chemistry and Chemical Engineering, Shanghai Jiao Tong University (SJTU) - MOE Key Laboratory of Systems Biomedicine (KLSB), Shanghai Jiao Tong University (SJTU) - MOE Key Laboratory of Systems Biomedicine (KLSB), University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), Institute for Systems Biology, Institute for Systems Biology, Institute for Systems Biology, California Institute of Technology - Division of Chemistry and Chemical Engineering, California Institute of Technology - Division of Chemistry and Chemical Engineering, University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), Fudan University - Shanghai Cancer Center (FUSCC), City of Hope - Department of Molecular and Cellular Biology, City of Hope - Department of Molecular and Cellular Biology, Institute for Systems Biology, Shanghai Jiao Tong University (SJTU) - MOE Key Laboratory of Systems Biomedicine (KLSB), University of California, Los Angeles (UCLA) - Department of Molecular and Medical Pharmacology (DMMP), University of California, Los Angeles (UCLA) - Department of Medicine, California Institute of Technology - Division of Biology and Biological Engineering, Peking University - Key Laboratory of Carcinogenesis and Translational Research, California Institute of Technology - Division of Chemistry and Chemical Engineering and Institute for Systems Biology
Downloads 16 (566,151)

Abstract:

Loading...

non-genetic drug resistance, epigenetic plasticity, chromatin remodeling, melanoma, targeted therapy resistance, multi-omics characterization, systems biology, information theory, dynamic systems, histone modification